Status of Blood Products Release at a General Hospital in Gyeonggi-Do

• Published in: Korean journal of clinical laboratory science Vol. 54; no. 1; pp. 73 - 77
• Main Authors: Choi, Ho-Keun, Choi, Kyung-Suk
• Format: Journal Article
• Language: English
• Published: The Korean Society for Clinical Laboratory Science 31-03-2022
• Subjects: appropriateness of transfusion; blood inventory; blood products; red blood cell preparation; suitable for transfusion
• ISSN: 1738-3544; 2288-1662
• DOI: 10.15324/kjcls.2022.54.1.73

Blood products (BPs) can only be obtained through blood donation and hence represent a finite resource. BPs should therefore be used conservatively. However, BPs are being used indiscriminately without evidence. The purpose of this study was to evaluate the reasons for the use of BPs and their appropriateness. The investigation was carried out based on hemoglobin levels. Data were obtained from Nov 1, 2020, to Oct 31, 2021, from a hospital’s OCS/EMR systems. The BPs were dispensed in 21,303 cases, and the number of hemoglobin levels ＞7.0 g/dL or higher among red blood cell drugs used by each treatment department was 1,173 (＞7.0 g/dL). The misuse of blood transfusions is increasing social costs, with the adequacy of transfusion becoming increasingly important. Hence, each medical institution should review the transfusion guideline evaluation index, check the status of the release of BPs, and institute educational programs covering transfusion guidelines and continually evaluate their adequacy.